Torulopsis glabrata an emerging yeast pathogen in cancer patients

scientific article published on 01 January 1999

Torulopsis glabrata an emerging yeast pathogen in cancer patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0924-8579(98)00066-1
P698PubMed publication ID10075271

P2093author name stringV Krcmery
P2860cites workAssociation of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patientsQ35819117
Importance of Candida species other than C. albicans as pathogens in oncology patientsQ40512068
Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazoleQ40520689
Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodesQ40735277
Fluconazole treatment of candidal infections caused by non-albicans Candida speciesQ71347439
Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational studyQ71598396
Candida glabrata, Candida krusei, non-albicans Candida spp., and other fungal organisms in a sixty-bed national cancer center in 1989-1993: no association with the use of fluconazoleQ72588936
P433issue1
P921main subjectTorulopsis glabrataQ105067985
P304page(s)1-6
P577publication date1999-01-01
P1433published inInternational Journal of Antimicrobial AgentsQ15724616
P1476titleTorulopsis glabrata an emerging yeast pathogen in cancer patients
P478volume11

Reverse relations

cites work (P2860)
Q48163274Candida glabrata Biofilms: How Far Have We Come?
Q38163927Candida glabrata: a review of its features and resistance
Q37352730Development of Candida-associated denture stomatitis: new insights
Q37950850Insights into Candida tropicalis nosocomial infections and virulence factors.
Q39466208Isolation and characterization of a species-specific DNA fragment for identification of Candida (Torulopsis) glabrata by PCR.
Q35116244Newer antifungal therapy for emerging fungal pathogens

Search more.